These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6689433)

  • 1. [KM 2210 therapy for chronic lymphocytic leukemia].
    Mori M; Murai Y; Miwa A; Fukayama M; Ikebuchi K; Nakamura N; Kaise M
    Gan No Rinsho; 1983 Dec; 29(15):1788-90. PubMed ID: 6689433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
    Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early phase II trial of bestrabucil in hematological malignancies].
    Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to busramustine (KM-2210) in chronic lymphocytic leukemia: a pilot evaluation of estrogen receptor in relation to its therapeutic effect.
    Nishikawa M; Uemura Y; Komada F; Ohno T; Katayama N; Shirakawa S
    Jpn J Clin Oncol; 1988 Dec; 18(4):327-33. PubMed ID: 3204682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study of chlorambucil in patients with hematological malignancies].
    Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2672-5. PubMed ID: 3307632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
    Knauf WU; Lissichkov T; Aldaoud A; Liberati A; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Tremmel L; Merkle K; Montillo M
    J Clin Oncol; 2009 Sep; 27(26):4378-84. PubMed ID: 19652068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
    Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
    Lutz D; Böhnel J
    Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biweekly chlorambucil treatment of lymphocytic lymphoma.
    Knospe WH; Loeb V
    Cancer Clin Trials; 1980; 3(4):329-36. PubMed ID: 7428139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
    Aungst CW; Mittelman A; Murphy GP
    J Surg Oncol; 1975; 7(6):457-60. PubMed ID: 1102806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chlorambucil therapy for chronic lymphocytic leukemia].
    Ota H; Morita A; Yasuma A
    Rinsho Ketsueki; 1973 Jan; 14(1):94-101. PubMed ID: 4734793
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
    Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
    Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal intraalveolar and interstitial lung fibrosis in chlorambucil-treated chronic lymphocytic leukemia.
    Refvem O
    Mt Sinai J Med; 1977; 44(6):847-51. PubMed ID: 304171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
    Isurugi K
    Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.
    Shustik C; Mick R; Silver R; Sawitsky A; Rai K; Shapiro L
    Hematol Oncol; 1988; 6(1):7-12. PubMed ID: 3277904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
    Naito K; Kubo K; Akao Y; Hiraiwa A; Naoe T; Yamada K
    Gan No Rinsho; 1986 Sep; 32(11):1443-50. PubMed ID: 2877106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status of chemotherapy in ALL and CLL].
    Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1882-7. PubMed ID: 6964032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.